학술논문

The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders.
Document Type
Article
Source
Journal of Clinical Medicine. Apr2023, Vol. 12 Issue 8, p2865. 18p.
Subject
*INFLAMMATORY bowel diseases
*PSORIATIC arthritis
*ULCERATIVE colitis
*ATOPIC dermatitis
*INFLAMMATION
*CELLULAR signal transduction
*INTERLEUKIN-22
Language
ISSN
2077-0383
Abstract
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway plays a critical role in orchestrating immune and inflammatory responses, and it is essential for a wide range of cellular processes, including differentiation, cell growth, and apoptosis. Over the years, this pathway has been heavily investigated due to its key role in the pathogeneses of several chronic inflammatory conditions, e.g., psoriasis, atopic dermatitis (AD), and inflammatory bowel diseases (IBDs). Nevertheless, the impact of this pathway on the pathogenesis of inflammatory conditions remains unclear. This review describes the role of the JAK/STAT signaling pathway in the pathogenesis of inflammatory diseases such as psoriasis (Pso), psoriatic arthritis (PsA), AD, and IBD with a focus on ulcerative colitis (UC) and briefly resumes the use of JAK inhibitors in their clinical management. [ABSTRACT FROM AUTHOR]